EP0518983A4 - Non-linting composite gauze material. - Google Patents
Non-linting composite gauze material.Info
- Publication number
- EP0518983A4 EP0518983A4 EP19910906141 EP91906141A EP0518983A4 EP 0518983 A4 EP0518983 A4 EP 0518983A4 EP 19910906141 EP19910906141 EP 19910906141 EP 91906141 A EP91906141 A EP 91906141A EP 0518983 A4 EP0518983 A4 EP 0518983A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- threads
- coating
- cellulose fiber
- polymer
- prepolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 26
- 239000000463 material Substances 0.000 title claims description 49
- 229920000742 Cotton Polymers 0.000 claims abstract description 41
- 229920000642 polymer Polymers 0.000 claims abstract description 32
- 229910001868 water Inorganic materials 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 229920003043 Cellulose fiber Polymers 0.000 claims abstract description 27
- 239000002250 absorbent Substances 0.000 claims abstract description 14
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 14
- 239000004094 surface-active agent Substances 0.000 claims abstract description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 9
- 229920005830 Polyurethane Foam Polymers 0.000 claims abstract description 8
- 239000011496 polyurethane foam Substances 0.000 claims abstract description 8
- 229920002635 polyurethane Polymers 0.000 claims abstract description 7
- 239000004814 polyurethane Substances 0.000 claims abstract description 7
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 4
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000000576 coating method Methods 0.000 claims description 22
- 239000011248 coating agent Substances 0.000 claims description 21
- 239000002657 fibrous material Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 231100000252 nontoxic Toxicity 0.000 claims description 6
- 230000003000 nontoxic effect Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000002897 polymer film coating Substances 0.000 claims 3
- 238000010521 absorption reaction Methods 0.000 claims 1
- 230000001464 adherent effect Effects 0.000 claims 1
- 229920003169 water-soluble polymer Polymers 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 11
- 230000002745 absorbent Effects 0.000 abstract description 4
- 241000219146 Gossypium Species 0.000 description 25
- 229920005989 resin Polymers 0.000 description 23
- 239000011347 resin Substances 0.000 description 23
- 239000000835 fiber Substances 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 229920002678 cellulose Polymers 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 238000007906 compression Methods 0.000 description 8
- 230000006835 compression Effects 0.000 description 8
- 239000006260 foam Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- 206010018691 Granuloma Diseases 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013618 particulate matter Substances 0.000 description 3
- 229920001993 poloxamer 188 Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- -1 polyoxyethylene Polymers 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 230000009969 flowable effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920001228 polyisocyanate Polymers 0.000 description 2
- 239000005056 polyisocyanate Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
- A61F13/00991—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder
- A61F13/00995—Apparatus or processes for manufacturing non-adhesive dressings or bandages for treating webs, e.g. for moisturising, coating, impregnating or applying powder for mechanical treatments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01042—Absorbency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00238—Wound bandages characterised by way of knitting or weaving
- A61F2013/00242—Wound bandages characterised by way of knitting or weaving to avoiding fraying or pilling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00314—Wound bandages with surface treatments
- A61F2013/00323—Wound bandages with surface treatments to make surface hydrophilic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00314—Wound bandages with surface treatments
- A61F2013/00336—Wound bandages with surface treatments polymeric resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00348—Wound bandages lint-free, i.e. non-linting or frying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
- A61F2013/0074—Plasters means for wound humidity control with absorbing pads containing foams
Definitions
- This invention relates to substantially lint-free cotton gauze. Specifically it relates to a durable hydrophilic substantially non-linting water-absorbent drapable composite material comprising hydrophilic polymer resin applied to cellulosic fiber materials.
- Cotton gauze is manufactured from twisted cotton fiber which is cleaned, bleached and sterilized. During the cleaning and bleaching process the thread is exposed to chemical treatments and becomes associated with leftover starch, proteins, casein, and resins. These materials, plus small fibers, can fall out of cotton gauze to contaminate a wound. During surgery, they may enter and remain undetected in the body to cause granulomas or they may enter the vascular system to cause even more serious conditions.
- cellulose gauze While cellulose gauze is hydrophilic, the cellulose fibers are not normally broken down by human enzyme systems. The chronic presence of such cellulose fibers remaining in a patient post-operation causes an immune reaction in the patient resulting in inflamation and adhesion. The problem is apparently worsened by use of woven cotton swabs, over use of nonwoven cotton swabs. See Levinson & Swolin, "Postoperative Adhesions: Etiology, Prevention, and Therapy", Clin. Obst. & Gyn., 23(4); 1213-1220 (1980).
- This invention involves wound dressing material which is substantially lint-free and highly water-absorbent.
- the composite material of this invention comprises an open weave cellulose fiber material, such as cotton gauze, coated with a hydrophilic polymer. Although coated with a polymer, the composite material is highly water-absorbent, drapable, elastic and non-toxic, thus suitable for use in place of conventional gauze during surgical procedures.
- the wound dressing material of the invention comprises an open weave cellulose fiber material having warp and fill threads. These threads are coated with a hydrophilic polymer film, leaving interstitial regions open among the threads.
- the polymer is believed to specifically bind with the hydroxyl groups of the cellulose substantially to eliminate free particulate matter.
- the cellulose fiber material may be woven cotton gauze, and is useful as a wound dressing or during surgery.
- the polymer may be a polyurethane foam prepolymer applied to the gauze in aqueous solution.
- the polymer may be a polyethylene oxide, or carboxymethyl cellulose, or a polyvinylpyrrolidone.
- the preferred prepolymer is a toluene diisocyanate terminated polyethylene glycol, available as TREPOLTM from Twin Rivers Engineering, Boothbay, Maine.
- the prepolymer aqueous solution may contain a surfactant, such as Pluronic® F68, available from BASF, to assure wetting.
- Pluronic® F68 available from BASF
- the polymer used to coat the cellulose fibers may be a blend of water to prepolymer in a ratio of from about 6:1 to about 400:1. This blend results in an increase in water absorbency, over untreated cotton gauze, usually in excess of 100 percent,' and often in excess of 200 percent.
- the water absorbency of polymer-coated cellulose fibers of the invention can be in the range of from about 300 to 450 percent (weight of absorbed water in 3-4.5 times weight of dry gauze), compared with the water absorbency of untreated cellulose fiber which absorbs in the range of from about 200 to 250 percent.
- the water to polymer ratio of the coating composition be sufficient effectively to bind particulate and resinous debris, without losing hydrophilicity, drapability or elasticity, and while maintaining an open weave structure.
- skilled chemical engineers can manufacture the polymer-coated cellulose fiber material for use as wound dressing material.
- Figure 1 illustrates the structure of an untreated section of woven cellulose fiber material showing warp and fill threads
- Figure 2 is a schematic detailed view the intersection of an untreated warp thread and an untreated fill thread showing unbound particulate and resinous debris;
- Figure 3 is a schematic detailed, partially broken away view of a thread coated in accordance with the invention.
- Figure 4 illustrates an intersection of warp and fill threads, coated with the polymer in accordance with the invention.
- Figure 5 is a schematic representation of a device for coating cellulose fiber material using the process of the invention.
- FIG. 1 depicts typical woven cotton gauze 10, having warp threads 12 and fill threads 14 which are interwoven defining interstitial regions 16 between the warps 12 and fills 14. The presence of such interstitial regions makes this material an open weave, which enhances its absorbency.
- Each thread of cotton gauze 10 is a twisting of multiple cotton fibers 11.
- the chief constituent of cotton fiber 11 is cellulose. See Merrill, Macormac & Mauersberger, American Cotton Handbook. 88-89 (1949). The forces holding native cotton fiber together are hydrogen bonds between the hydroxyl groups in the cellulose.
- the structure of cotton fiber 11 is that of many anhydroglucose units joined by an oxygen bridge between the 1:4 carbons to give long cellulose chains.
- cotton fiber 11 also contains other materials such as proteins, waxes, and pectin. Thus, .there is some particulate matter associated with natural cotton fiber.
- Cotton gauze 10, used primarily as a wound dressing is manufactured from twisted cotton fiber which is cleaned, bleached and sterilized. During the cleaning and bleaching process the thread is exposed to chemical treatments including combinations of acids, enzymes, alkalies, soda, sodium silicate, chlorine, sodium hydroxide, sulfuric acid, silicate of soda, turkey red oil or hydrogen peroxide.
- Unbound particulate cotton fiber matter 20 and resinous debris 22, depicted in FIG. 2 may be left behind in wounds when cotton gauze is used as wound dressing material, causing adhesion and granulomas.
- a polymer coating 25 may be used to cover the individual cotton warp threads and fill threads.
- FIG's. 3 and 4 depict how the polymer coating 25 binds particulate cotton fiber material 20 and resinous debris 22 in accordance with the invention. Notice from FIG. 4 that the interstitial space 16 is maintained open and is not filled in with the polymer coating 25. This is important in maintaining a high degree of absorptivity.
- the polymer coating produces polymer "fillets” 18 at the corner intersections of the warp 12 and fill 14 of the composite gauze material.
- the fillets 18 consist of the polymer connection at the junction of warp and fill threads. They enable the material to better maintain and conserve the open weave structure during use. In untreated cotton gauze, there is resistance to deformation in the longitudinal direction, however the gauze is readily tearable in the lateral direction. The presence of the fillets 18 enhances the tensile strength of the material.
- the composite material is made by applying a thin film of hydrophilic polymer to preformed woven cellulose fiber material of the type shown in FIGURE 1, i.e., conventional gauze.
- Cellulose has several free hydroxyl groups which may react with a hydrophilic polymer forming covalent bonds.
- the cellulose acts as a hydroxyl donor which can bond with an introduced polymer.
- the polymer system used to form the coating typically is a thermosetting prepolymer mixture dissolved in an aqueous vehicle which, when cross-linked, is not water soluble.
- the viscosity of the solution is important in achieving the thread-enveloping coating that maintains the open weave structure of the gauze. Viscosity and wettability of the coating solution is controlled in particular cases by adjusting the prepolymer/water ratio and blending with various surface active agents.
- the treatment chemical is the prepolymer polyethylene oxide, available from Union Carbide.
- This polymer forms a good association with compounds such as carboxy methyl cellulose, and also is reactive toward a hydroxyl donor, such as cellulose.
- the polyethylene oxide may be mixed with the carboxy methyl cellulose at a ratio of 1:1.
- polyethylene oxide and methyl cellulose are separately mixed at 6% by weight in water, then combined in a ratio of 1:1.
- the resulting solution is applied to the gauze.
- the solution cross-links, with irradiation, with the gauze and, in curing, forms an insoluble hydrophilic film on the individual threads thereof which retains free particulates.
- This composite material may absorb as much as 1400 times its weight in water or more.
- the treatment chemical is polyvinylpyrrolidone (see U.S. Patent No. 4,192,827).
- the currently preferred polymer is a hydrophilic polyurethane foam prepolymer applied from aqueous solution and then reacted in situ.
- the polyurethane foam may utilize any of a variety of urethane prepolymers normally employed for reaction to provide a reticulated, open cell foam.
- a preferred class of hydrophilic urethane prepolymers includes, for example, isocyanate terminated or capped polyoxyalkylene ethers including polyoxyethylene polyol prepolymers. Suitable prepolymers are described in U.S. Patent No.
- the preferred prepolymer is TREPOLTM polyurethane prepolymer available from Twin Rivers Engineering, Route #27, Boothbay, Maine, 04537.
- the TREPOLTM prepolymer is a polyisocyanate terminated polyethylene polyol with less than 6% available unreacted NCO groups and a component functionality of 2 or less.
- HYPOL 3000TM prepolymer may be used.
- HYPOL 3000TM is a polyisocyanate capped polyoxyethylene polyol prepolymer having a reaction functionality of the prepolymer molecules greater than 2, and is available from W.R. Grace Company of New York.
- exemplary surfactants include: Schercopol OMS-N, a disodium monooleamido MEA sulfosuccinate, available from the Scher Chemicals, Inc., Industrial West, Clifton, New Jersey 07012; PPG 1025, a polypropylene glycol surfactant; Pluronic® F68 or Pluronic® P75, nonionic surfactants which are block copolymers of propylene oxide and ethylene oxide, available from BASF; or, Alcolec HS-3, an active combination of lecithin and sulfonated glycerides in an aqueous solution, available from American Lecithin Company, 32-34 61st Street, Woodside, Long Island, New York 11377.
- the hydrophilic prepolymer is activated by the aqueous phase for polymerization upon mixing.
- the aqueous phase and the prepolymer are mixed together in a ratio by weight of aqueous phase to prepolymer sufficient to set an appropriate workable viscosity.
- this ratio typically is in the range of from about 6:1 to about 400:1.
- the solution constitutes a flowable, liquid incipient polyurethane which subsequently cures in situ after adhering to the threads.
- the incipient foam is deposited on the open weave cellulose threads and excess water permeates the fiber.
- hydrophilic urethane prepolymer in the ratio of from about 6:1 aqueous phase to prepolymer, to about 400:1 aqueous phase to prepolymer can produce a coated product that is highly water absorbent and meets the physical characteristics of durability, flexibility and drapablility.
- the high water content of the mixture substantially eliminates foam formation when applied as a thin film to cotton gauze.
- the result is a polymer coating which is water absorptive in combination with the cotton substructure, but does not have discrete, well defined cells.
- the excess water in the polymerization reaction mixture permits adjustment of viscosity to allow the resulting solution to be applied readily to the threads of the cotton gauze. This rheological property of the solution permits automated production. Excess water also helps to dissipate exothermic heat and to limit the temperature of the reaction. Finally, the excess water assures that all available isocyanate sites are consumed or reacted, assuming nontoxicity of the resulting composition.
- Co-pending U.S. Application Serial No. 013,255 teaches a method of manufacturing composite materials by use of a machine illustrated in FIG. 5.
- the cotton gauze material with the incipient foamed resin of this invention can be manufactured using this type of equipment.
- the aqueous resin coated gauze may be compressed to insure impregnation of the web with the resin and to establish the degree to which the polymer will occupy the interstitial regions of the fibers. Compression occurs at the adjustable nip of compression means 40, or between upper and lower parallel belts or conveyors of similar function (not shown) .
- compression may occur between mold halves configured to impart shape to the surface of the composite material (not shown). In general, higher degrees of compression reduce the relative amount of incipient foam resin (lower foam density) and tend to promote greater preservation of voids among the fibers.
- FIGURE 5 shows in schematic form the apparatus for performing the several steps of the method.
- the woven cotton gauze fibrous material 30 is unrolled from supply rolls 32 and is advanced horizontally .
- the individual sheets of material 30 pass through gathering means 33.
- Blended liquid polyurethane foam resin or other hydrophilic resin is dispensed from a blender/dispenser means 34 and is deployed over the surface of the material 30.
- the flowable, liquid incipient resin is allowed to penetrate the material 30 as the web advances.
- the resin-coated material 36 is compressed by compression means 40 which may comprise, as is illustrated, an adjustable nip between a pair of compression rollers 41, 42.
- the compression means 40 further distributes and makes uniform the resin within the material 36 and, by compression of the material, establishes the relative quantity, and therefore density distribution, of incipient resin carried within the material, thereby controlling the degree to which the foam will occupy the interstitial regions among the fibers of the material.
- the resin-coated material is then taken through a curing means 50 where completion of the polymerization and curing of the urethane takes place.
- the curing means 50 may include air heaters 52 or heated rollers (not shown) or both.
- the curing means 50 may also comprise an exhaust fan system 54.
- the polymer reaction and coating process may occur at room temperature.
- the composite material 55 may pass over separation rollers 56, which assists in keeping multiple sheets of composite material 55 separated during the curing process.
- the composite material 55 may pass through a pair of drive rollers 58, 59 and onto a take-up roll 60.
- the drive rollers 58, 59 allow for multiple layers of composite material 55 to be combined into a single sheet for multi-layer gauze.
- Cotton gauze may be treated as it is unrolled from its storage roll, or may be treated in • strips. Gauze also may be dipped in the polymer and massaged, rolled, or hung to dry. After extraction or evaporation of any liquid vehicles, which may be by room temperature or oven drying, the cured composite material may be cut to size or rolled as stock.
- the effectiveness of the gauze treatment may be tested by putting test strips into boiling water and allowing the strip to be tossed around at a boil.
- the resulting effluent then may be passed through a particle counter, such as a Coulter-counter.
- a particle counter such as a Coulter-counter.
- EG/HS-3 is a mixture of two surfactants: Emulgade 100NI, supplied by Henkel Corporation, which is a mixture of cetearyl alcohol and ceteaseth-20; and Alcolec HS-3, an active combination of lecithin and sulfonated glycerides in aqueous solution, supplied by American Lecithin Company. Emulgade and HS-3 were each made into 2.5% aqueous solutions, then mixed together to form a 95% water solution (or 5% EG/HS-3 aqueous solution).
- F68 is Pluronic® F68, a nonionic surfactant of block copolymers of propylene oxide and ethylene oxide, supplied by BASF.
- TREPOLTM is a toluene diisocyanate terminated polyethylene glycol with less than 6% available unreacted NCO groups and a component functionality of 2 or less. It is available from Twin Rivers Engineering, Route 27, Boothbay, Maine, 04537.
- a surfactant such as F68
- examples 2-3 illustrate that varying amounts of prepolymer, in combination with surfactant EG/HS-3, does not affect resin fallout.
- examples 4-5 varying the amount of F68 surfactant alone does not affect resin fallout.
- Examples 6-8 illustrate various ratios of water to prepolymer, whereby lower prepolymer concentration results in "closed gauze". Closed gauze is gauze with filled interstitial regions.
- Examples 9-16 illustrate the effect of varying concentrations of prepolymer TREPOLTM to water on fiber and resin fallout. As demonstrated by these examples, an optimal ratio of 99.5 parts water, 0.5 parts surfactant F68, and 12 parts prepolymer TREPOLTM may result in a desired zero fiber fallout and zero resin fallout.
- Example 11 differs from example 10 in that air was blown through the coated gauze in Example 11 to open the windows in the gauze. As demonstrated by this example 11, this additional step renders the gauze treatment suboptimal.
- the invention may be embodied in other specific forms.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Manufacturing & Machinery (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48937990A | 1990-03-06 | 1990-03-06 | |
US489379 | 1990-03-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0518983A1 EP0518983A1 (en) | 1992-12-23 |
EP0518983A4 true EP0518983A4 (en) | 1994-03-24 |
Family
ID=23943614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19910906141 Withdrawn EP0518983A4 (en) | 1990-03-06 | 1991-02-26 | Non-linting composite gauze material. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0518983A4 (en) |
CN (1) | CN1054539A (en) |
AU (1) | AU7468491A (en) |
CA (1) | CA2077648A1 (en) |
WO (1) | WO1991013602A1 (en) |
ZA (1) | ZA911606B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9102089D0 (en) * | 1991-01-31 | 1991-03-13 | Johnson & Johnson Medical | Net wound dressings |
US6743965B2 (en) * | 2000-12-21 | 2004-06-01 | Mcneil-Ppc, Inc. | Apertured polymeric film web with diol/surfactant additive |
EP3167857B1 (en) * | 2010-08-04 | 2020-10-28 | Medline Industries, Inc., | Medical towel and method for manufacturing |
CN103749493B (en) * | 2014-02-14 | 2016-01-27 | 南京南农农药科技发展有限公司 | Suspending agent of a kind of composite bactericide containing jinggangmycin A and thifluzamide and preparation method thereof |
CN109923151B (en) | 2016-11-03 | 2021-08-20 | 3M创新有限公司 | Silicone copolymers, methods of manufacture, and articles |
CN108355162B (en) * | 2018-05-14 | 2021-07-23 | 江西省科学院应用化学研究所 | Medical dressing of antibiotic hydrophilic polyurethane foam |
CN114288090B (en) * | 2021-12-30 | 2023-01-10 | 福建恒安卫生材料有限公司 | Preparation method of disposable hygienic product with oxygen slow release function |
CN115120771A (en) * | 2022-06-30 | 2022-09-30 | 长沙海润生物技术有限公司 | Pre-convergent laser sintering gauze dressing and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2764976A (en) * | 1955-01-10 | 1956-10-02 | Johnson & Johnson | Dressing |
US3317367A (en) * | 1963-04-12 | 1967-05-02 | Du Pont | Hydrophobic fiber structure with interconnected non-fibrous hydrophilic network |
GB2192142B (en) * | 1986-07-04 | 1990-11-28 | Johnson & Johnson | Wound dressing |
-
1991
- 1991-02-26 WO PCT/US1991/001354 patent/WO1991013602A1/en not_active Application Discontinuation
- 1991-02-26 CA CA002077648A patent/CA2077648A1/en not_active Abandoned
- 1991-02-26 AU AU74684/91A patent/AU7468491A/en not_active Abandoned
- 1991-02-26 EP EP19910906141 patent/EP0518983A4/en not_active Withdrawn
- 1991-03-05 ZA ZA911606A patent/ZA911606B/en unknown
- 1991-03-06 CN CN91101469A patent/CN1054539A/en active Pending
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
EP0518983A1 (en) | 1992-12-23 |
ZA911606B (en) | 1991-12-24 |
AU7468491A (en) | 1991-10-10 |
CN1054539A (en) | 1991-09-18 |
WO1991013602A1 (en) | 1991-09-19 |
CA2077648A1 (en) | 1991-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5135472A (en) | Non-linting composite gauze material | |
CA2154473C (en) | Carboxymethylcellulose wound dressings | |
JP5581328B2 (en) | Liquid absorbent material | |
CA1066466A (en) | Polyurethane foam surgical dressing | |
US6534083B2 (en) | Hydrogels | |
EP2773799B1 (en) | Knitted structure for wound dressings | |
US5676660A (en) | Absorbent product including absorbent layer treated with surface active agent | |
CA2335563C (en) | Wound dressings and materials suitable for use therein | |
DE69530180T2 (en) | WOUND DRESSING | |
Doh et al. | Manufacturing and analyses of wet-laid nonwoven consisting of carboxymethyl cellulose fibers | |
WO1994016746A1 (en) | Wound dressings | |
US6458460B1 (en) | Wound dressing | |
JPH0382893A (en) | Longitudinal wicking structure of wet bridge structure cellulose fiber | |
EP0518983A4 (en) | Non-linting composite gauze material. | |
US6153214A (en) | Wound dressing and manufacture thereof | |
CN117481910A (en) | Nano silver antibacterial band-aid | |
WO2005067988A1 (en) | Huckaback woven wound dressing | |
CZ76199A3 (en) | Wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19921001 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19950821 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19970902 |